Which medication requires reporting shortness of breath as a potential adverse effect?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Enhance your preparation for the HESI exam with targeted questions and detailed explanations. Utilize practice quizzes to grasp essential concepts and improve your readiness for success.

Multiple Choice

Which medication requires reporting shortness of breath as a potential adverse effect?

Explanation:
Shortness of breath signals a possible infusion-related reaction to infliximab, a monoclonal antibody used for autoimmune diseases. Because these reactions can occur during or after the IV infusion and may progress to more serious events like anaphylaxis, reporting new or worsening dyspnea right away is essential so the infusion can be paused and appropriate treatment started. While other medications have their own adverse effects, infliximab carries a notable risk of infusion-related respiratory symptoms, making SOB a key side effect to monitor and report.

Shortness of breath signals a possible infusion-related reaction to infliximab, a monoclonal antibody used for autoimmune diseases. Because these reactions can occur during or after the IV infusion and may progress to more serious events like anaphylaxis, reporting new or worsening dyspnea right away is essential so the infusion can be paused and appropriate treatment started. While other medications have their own adverse effects, infliximab carries a notable risk of infusion-related respiratory symptoms, making SOB a key side effect to monitor and report.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy